Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiki Kayano

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Scientific Reports|January 8, 2022
Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during <sup>131</sup>I-meta-iodo-benzyl-guanidine therapyYuka Taniguchi, Hiroshi Wakabayashi, Hiroto Yoneyama, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|June 5, 2020
[The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis]Hiroshi Mori, Anri Inaki, Daiki Kayano, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|August 6, 2019
Utility of <sup>123</sup>I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and ParagangliomaHiroshi Wakabayashi, Tahahiro Konishi, Hiroto Yoneyama, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatmentJunichi Taki, Takahiro Higuchi, Atsuhiro Kawashima, et al.
Annals of Nuclear Medicine|April 9, 2014
Application of a medium-energy collimator for I-131 imaging after ablation treatment of differentiated thyroid cancerMasato Kobayashi, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|October 14, 2021
Prognostic factors for refractory pheochromocytoma and paraganglioma after <sup>131</sup>I-metaiodobenzylguanidine therapyTomo Hiromasa, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|June 26, 2019
Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017Yoshihiro Nishiyama, Seigo Kinuya, Takashi Kato, et al.
Hellenic Journal of Nuclear Medicine|October 19, 2013
Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancerMasato Kobayashi, Hiroshi Wakabayashi, Hironori Kojima, et al.
Journal of the Neurological Sciences|July 26, 2014
Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic areaRyoichi Takahashi, Kenjiro Ono, Shutaro Shibata, et al.
Endocrine Journal|December 25, 2022
Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in JapanNorihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Scientific Reports|January 8, 2022
Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during <sup>131</sup>I-meta-iodo-benzyl-guanidine therapyYuka Taniguchi, Hiroshi Wakabayashi, Hiroto Yoneyama, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|June 5, 2020
[The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis]Hiroshi Mori, Anri Inaki, Daiki Kayano, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|August 6, 2019
Utility of <sup>123</sup>I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and ParagangliomaHiroshi Wakabayashi, Tahahiro Konishi, Hiroto Yoneyama, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2007
Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatmentJunichi Taki, Takahiro Higuchi, Atsuhiro Kawashima, et al.
Annals of Nuclear Medicine|April 9, 2014
Application of a medium-energy collimator for I-131 imaging after ablation treatment of differentiated thyroid cancerMasato Kobayashi, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|October 14, 2021
Prognostic factors for refractory pheochromocytoma and paraganglioma after <sup>131</sup>I-metaiodobenzylguanidine therapyTomo Hiromasa, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|June 26, 2019
Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017Yoshihiro Nishiyama, Seigo Kinuya, Takashi Kato, et al.
Hellenic Journal of Nuclear Medicine|October 19, 2013
Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancerMasato Kobayashi, Hiroshi Wakabayashi, Hironori Kojima, et al.
Journal of the Neurological Sciences|July 26, 2014
Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic areaRyoichi Takahashi, Kenjiro Ono, Shutaro Shibata, et al.
Endocrine Journal|December 25, 2022
Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in JapanNorihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, et al.
Pageof 4